Florida · 2026 Regular Session · Bill
SB 222: Cost-sharing Requirements for Diabetes Management
Did not advance Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
- Did not advance
Last official action: ·Record last updated:
Plain-language summary
SB 222 is a bill introduced in the Florida Senate on October 17, 2025. According to its official title, it concerns: Cost-sharing Requirements for Diabetes Management. Primary sponsor: Smith. It lists 2 additional sponsors. Most recent recorded action (March 13, 2026): Died in Banking and Insurance.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Cost-sharing Requirements for Diabetes Management; Prohibiting health insurance policies from imposing a cost-sharing requirement exceeding a certain amount for a 30-day supply of insulin or any diabetes device or diabetic ketoacidosis device, etc.
Sponsors
Sponsors by party (alphabetical): Democratic 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Smith | Primary sponsor | Not applicable (committee) | — | — |
| Kristen Arrington | Co-sponsor | Democratic | Senate | 25 |
| Rosalind Osgood | Co-sponsor | Democratic | Senate | 32 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Died in Banking and Insurance
- Introduced
- Referred to Banking and Insurance; Appropriations Committee on Agriculture, Environment, and General Government; Fiscal Policy
- Filed